Recently, Nanjing GQ Laboratories Co., Ltd. (referred to as "GQ Labs") passed the CNAS on-site audit and successfully obtained the Laboratory National Accreditation Certificate (Certificate Registration No.: CNAS L15279). Laboratory accreditation work plays a significant role in promoting the improvement of laboratory management and technology. After obtaining laboratory accreditation, GQ Labs' test data gains mutual recognition from member countries of the Asia Pacific Laboratory Accreditation Cooperation Mutual Recognition Arrangement (APLAC-MRA) and the International Laboratory Accreditation Cooperation Mutual Recognition Arrangement (ILAC-MRA). This is a landmark significance for expanding the authority, impartiality, and international influence of GQ Labs' test results. GQ Labs will take this certification as a new starting point, continuously improving testing levels and quality management levels to provide clients with high-quality service!
广祺医药将以此次认证为新起点，持续不断提高检测水平和质量管理水平，为客户提供最好的服务！
About GQ Labs
The company was established in August 2018. In the Jiangsu Life Science Park, Qixia District, Nanjing, a standardized and regulated bioanalysis platform and drug metabolism & PK/PD research platform was constructed in the first phase. It is equipped with high-end detection instruments such as LC-MS/MS and microplate readers, professional software like Watson LIMS and WinNonlin, and possesses an experimental management system that complies with international standards.
Within the current team, about 30 % hold a Master's degree or higher, and 67 % have over 5 years of experience in the pharmaceutical industry. The team has rich experience in pharmacokinetics R&D and international cooperation and maintains close collaboration with the State Key Laboratory of Pharmacokinetics at China Pharmaceutical University. It possesses key technologies for bioequivalence of special drug types (endogenous, prodrugs, highly variable, etc.). With biological sample testing as the core, covering clinical data management, bioequivalence study design, and data statistics, it provides integrated services for drug consistency evaluation and will actively develop innovative drug R&D and clinical pharmacokinetics research.
